Is PDEX research on Rallies investment advice?

No. Rallies provides research, data, and educational context for PDEX. It does not provide personalized investment advice.

PDEX (Pro-Dex Inc New) Stock Analysis - Financials

Pro-Dex Inc New (PDEX) is a publicly traded Healthcare sector company. As of September 3, 2026, PDEX trades at $65.20 with a market cap of $199.80M and a P/E ratio of 17.50. PDEX moved +0.00% today. Year to date, PDEX is +63.71%; over the trailing twelve months it is +35.00%. Its 52-week range spans $23.47 to $70.26. Rallies surfaces PDEX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are PDEX's key financials?

PDEX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. PDEX recently traded at $65.20. Market cap is $199.80M. P/E ratio is 17.50. Revenue is $72.10M.

PDEX Key Metrics

Key financial metrics for PDEX
Metric	Value
Price	$65.20
Market Cap	$199.80M
P/E Ratio	17.50
EPS	$3.47
Dividend Yield	0.00%
52-Week High	$70.26
52-Week Low	$23.47
Volume	52.85K
Avg Volume	0
Revenue (TTM)	$72.10M
Net Income	$2.52M
Gross Margin	28.29%

PDEX Analyst Consensus

PDEX analyst coverage data. Average price target: $0.00.

Common questions about PDEX

What are PDEX's key financials?: PDEX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. PDEX recently traded at $65.20. Market cap is $199.80M. P/E ratio is 17.50. Revenue is $72.10M.
Is PDEX research on Rallies investment advice?: No. Rallies provides research, data, and educational context for PDEX. It does not provide personalized investment advice.